Sand Hill Global Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Sand Hill Global Advisors's VRTX Position: Q1 2026 in Review
Sand Hill Global Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 23% in Q1 2026, buying an estimated $556K and bringing the position to 6,369 shares worth $2.84M. The position accounts for 0.1% of the portfolio, ranked #92.
Sand Hill Global Advisors first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.36M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Sand Hill Global Advisors held 6,369 shares of Vertex Pharmaceuticals worth $2.84M as of Q1 2026.
- Sand Hill Global Advisors bought 1,193 Vertex Pharmaceuticals shares in Q1 2026, an estimated $556K.
- Vertex Pharmaceuticals made up 0.1% of Sand Hill Global Advisors's portfolio in Q1 2026, its #92 holding.
- Sand Hill Global Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- Sand Hill Global Advisors's Vertex Pharmaceuticals position peaked at $3.36M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Sand Hill Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.